BPA Call 15BNAS20A00000070-15B30221FWB110012
- Not listed
- Quest Diagnostics Incorporated, doing business as Quest Diagnostics, was awarded a $694,861.78 firm fixed price blanket purchase agreement (BPA) call contract by the Department of Justice Bureau of Prisons' (DOJ-BOP) Federal Correctional Complex Coleman to provide general laboratory services. Performance will take place at the Coleman facility located in Collegeville, Pennsylvania over a thirty-month period from March 2020 through December 2021. The contract was awarded under the Medical...
- This federal contract award was made by the Federal Correctional Complex Coleman, which is part of the U.S. Department of Justice's Bureau of Prisons, to Quest Diagnostics Incorporated, a provider of diagnostic information services. The $90,000.00 firm-fixed-price purchase order is for laboratory services with a completion date of July 24, 2015. The contract was not set aside for any special designation. Quest Diagnostics has provided a range of medical laboratory testing and analysis services...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Coleman awarded a firm fixed price blanket purchase agreement (BPA) call contract to Quest Diagnostics Incorporated for COVID-19 employee testing services. Under the terms of the contract, Quest Diagnostics will provide polymerase chain reaction (PCR) self-collection kits to Bureau of Prisons employees for SARS-CoV-2 testing through December 7, 2022. The potential value of the contract is $0. The place of performance is the...
- Quest Diagnostics Incorporated was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Department of Justice Bureau of Prisons Federal Correctional Institution Bennettsville to provide laboratory services for COVID-19 testing. The contract has a period of performance through August 26, 2022 and a potential value of $0.00. As the largest commercial laboratory testing organization in the United States, Quest Diagnostics will leverage its extensive nationwide network of...
- This is a task order awarded to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, to provide general laboratory testing services to the Federal Correctional Complex in Coleman, Florida from October 2023 through June 2024. The task order is part of a Blanket Purchase Agreement (BPA) contract with a total ceiling value of $293,882.06. The BPA was originally awarded by the Federal Bureau of Prisons, a civilian agency under the U.S. Department of Justice, and does not have a...
- Quest Diagnostics Incorporated received a task order award valued at $100,000 under Blanket Purchase Agreement 15BNAS26A00000038 from the Federal Correctional Complex Coleman, a civilian agency within the Bureau of Prisons. The task order covers one month of performance for general laboratory testing services during April 2026 and is structured as a firm fixed-price engagement with no set-aside designation. Quest Diagnostics will perform services at its facility in Secaucus, New Jersey,...
- Quest Diagnostics Incorporated, doing business as Quest Diagnostics, has been awarded a $555,267 firm fixed price blanket purchase agreement (BPA) call contract by the Department of Justice Bureau of Prisons (DOJ-BOP) Federal Correctional Institution (FCI) Phoenix to provide COVID-19 testing services. Performance will take place in Collegeville, Pennsylvania under the one-year contract scheduled to run from October 1, 2020 through June 30, 2021. As the prime contractor, Quest Diagnostics will...
- This is a firm fixed-price purchase order awarded by the Federal Correctional Complex Coleman, which is part of the U.S. Department of Justice's Bureau of Prisons. The $90,000 contract provides laboratory services to the agency and does not have a set-aside designation. The prime contractor is Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract has an ultimate completion date of June 30, 2015. Quest Diagnostics has previously provided COVID-19 and other...
- Quest Diagnostics Incorporated, doing business as Quest Diagnostics, was awarded a Blanket Purchase Agreement (BPA) call worth $8,763.00 by the Department of Justice Bureau of Prisons Federal Detention Center Philadelphia for laboratory testing services, including COVID-19 testing. The award has a completion date of March 21, 2024 and is not a set-aside contract. Quest Diagnostics has provided similar clinical laboratory testing and analysis services to various federal agencies, including the...
- Quest Diagnostics Incorporated has been awarded a $2,300 firm fixed price call against the Department of Justice Bureau of Prisons' Federal Correctional Institution in Greenville, Pennsylvania's blanket purchase agreement for COVID-19 test kits. Under this contract, Quest Diagnostics will provide COVID-19 testing services to the Bureau of Prisons facility in Collegeville, Pennsylvania, helping the agency conduct coronavirus screening for the inmate population as the pandemic continues. As the...
- 15BNAS20A00000070Blanket Purchase Agreement
- 15BNAS20A00000070-15B30221FWB110012BPA Call
Quest Diagnostics Incorporated, doing business as Quest Diagnostics, has been awarded a one-year, firm fixed price blanket purchase agreement (BPA) call contract valued at approximately $1.2 million by the Department of Justice Bureau of Prisons (DOJ-BOP) Federal Correctional Complex Coleman (FCC Coleman) to provide viral lab services. Under this contract, Quest Diagnostics will deliver COVID-19 and other viral testing and analysis to support FCC Coleman, a high-security United States penitentiary located in Collegeville, Pennsylvania. No set aside designation or subcontractor information was provided. This award draws on an existing BPA and will help the DOJ-BOP maintain health and safety at this federal prison through the end of 2021 as the COVID-19 pandemic continues.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| A00004 | Funding Only Action | ($43k) | 9/22/21 | |
| A00003 | Funding Only Action | $400.0k | 5/4/21 | |
| A00002 | Funding Only Action | $298.0k | 2/16/21 | |
| A00001 | Funding Only Action | $247.1k | 12/7/20 | |
| Not listed | Not listed | $251.0k | 10/19/20 |